NTLA — Intellia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Intellia Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	749	1,193	912	602	450
Net Total Accounts Receivable
Net Total Receivables	2.03	3.77	36.5	8.52	9.47
Prepaid Expenses
Total Current Assets	769	1,217	998	640	528
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	100	161	148	247	124
Long Term Investments
Other Long Term Assets
Total Assets	1,294	1,520	1,301	1,191	842
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	126	127	115	111	104
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	254	285	251	319	171
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,040	1,236	1,050	872	671
Total Liabilities & Shareholders' Equity	1,294	1,520	1,301	1,191	842
Total Common Shares Outstanding